BDLIB
EW icon

Banque de Luxembourg Investments (BLI)’s Edwards Lifesciences EW Stock Holding History

Banque de Luxembourg Investments (BLI)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9M Sell
119,491
-50,039
-30% -$4.19M 0.39% 67
2026
Q1 		$14.4M Hold
169,530
– – 0.43% 62
2025
Q4 		$14.6M Buy
+169,530
New +$13.9M 0.43% 63
2025
Q3 		– Sell
-61,500
Closed -$4.81M – 175
2025
Q2 		$4.81M Buy
+61,500
New +$4.59M 0.14% 125

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Banque de Luxembourg Investments (BLI)'s EW Position: Q2 2026 in Review

Banque de Luxembourg Investments (BLI) reduced its Edwards Lifesciences (EW) stake by 30% in Q2 2026, selling an estimated $4.19M and leaving 119,491 shares worth $10.9M. The position accounts for 0.39% of the portfolio, ranked #67.

Banque de Luxembourg Investments (BLI) first reported a position in EW in Q2 2025 and has held it in 4 quarters since. The position peaked at $14.6M in Q4 2025. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Banque de Luxembourg Investments (BLI) held 119,491 shares of Edwards Lifesciences worth $10.9M as of Q2 2026.
  • Banque de Luxembourg Investments (BLI) sold 50,039 Edwards Lifesciences shares in Q2 2026, an estimated $4.19M.
  • Edwards Lifesciences made up 0.39% of Banque de Luxembourg Investments (BLI)'s portfolio in Q2 2026, its #67 holding.
  • Banque de Luxembourg Investments (BLI) first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 4 quarters since.
  • Banque de Luxembourg Investments (BLI)'s Edwards Lifesciences position peaked at $14.6M in Q4 2025.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q2 2026, filed 10 Aug 2026.